Pfizer usually has a contest to see who can name the drug. I participated in the naming of atorvastatin + amlodipine, although my admittedly crappy suggestions didn't win.
The winner, of course, was Caduet (CAD = coronary artery disease; duet = the combo of atorvastatin and amlodipine). Brilliant name, not so brilliant product.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.